CN104721456A - Chinese herbal medicine for treating osteoproliferation - Google Patents
Chinese herbal medicine for treating osteoproliferation Download PDFInfo
- Publication number
- CN104721456A CN104721456A CN201510174693.0A CN201510174693A CN104721456A CN 104721456 A CN104721456 A CN 104721456A CN 201510174693 A CN201510174693 A CN 201510174693A CN 104721456 A CN104721456 A CN 104721456A
- Authority
- CN
- China
- Prior art keywords
- parts
- osteoproliferation
- treating
- herbal medicine
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine for treating osteoproliferation. The Chinese herbal medicine for treating the osteoproliferation is prepared from, by weight, 6-12 parts of herba ephedra, 8-11 parts of semen cuscutae, 6-12 parts of angelica sinensis, 4-8 parts of notopterygium roots, 10-15 parts of rhizoma drynariae, 8-12 parts of rhizoma cyperi, 7-14 parts of monkshood and 8-13 parts of red peony roots. According to the theory of traditional Chinese medicine, the Chinese herbal medicine for treating the osteoproliferation is capable of clearing and activating the channels and collaterals, tonifying muscles and bones, strengthening the loins, invigorating the kidney, regulating yin, tonifying yang, activating blood, diminishing swelling, detoxifying and easing pain. The Chinese herbal medicine for treating the osteoproliferation is mainly used for treating lumbar intervertebral disc protrusion and osteoproliferation diseases with the symptoms such as pain, numbness, swelling and no strength of upper and lower limbs due to pressure on the nerves, and has good clinical effects.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine for the treatment of hyperosteogeny.
Background technology
Bone matrix hyperplasia is also called hyperplastic osteoarthritis, osteoarthritis etc., soft tissue degeneration, the degeneration such as cartilage, intervertebral disc, ligament owing to forming joint, joint margins forms bony spur, synovial membrane plumpness waits change, and occurs osteoclasia, causes insecondary hyperosteogeny, cause joint deformity, when being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Hyperostosis constitutional estranged and Secondary cases two kinds.The traditional Chinese medical science thinks that primary disease is relevant with wound, strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc.
The pathogenic factor that hyperosteogeny is general is generally: 1, wound factor causes the change of the knee joint heavy burden line of force due to the factor such as damage, deformity of knee or inflammation, the effective weight-bearing area of knee joint surface is reduced, articular surface discontinuity, impulsive force concentrates position that the damage of articular cartilage easily occurs, and cause the small fracture of bone trabecula (sub-fracture), occur that sclerotin subsides, then occur Subchondral bone sclerosis phenomenon subsequently.Meanwhile, because the articular cartilage matrix of knee joint hyperosteogeny patient and knuckle synovia composition change, lose the elasticity of cartilage and the lubrication of surrounding synovial fluid, therefore make cartilage easily frayed.And the one that knee joint peripheral osteophytosis is joint injury repairs phenomenon, body, for increasing joint weight-bearing area, reduces and bears pressure and occur compensatory osteophytosis.2, after autoimmune response knee cartilage is subject to the factors disrupt such as mechanicalness, " sequestered antigen " of articular chondrocytes, mucopolysaccharide and collagen protein exposes, and causes autoimmune response, causes cartilage secondary injury.Often there is arthroncus, repeatedly articular synovitis in knee joint hyperosteogeny patient, the increase of common mononuclear cell, immunoglobulin and complement in synovial fluid, in synovial membrane congested obviously and monocyte infiltration, these all point out knee joint hyperosteogeny may be relevant with autoimmune response.
Current treatment hyperosteogeny generally takes physiotherapy, treatment by Chinese herbs and western medicine, and the physiotherapy general treatment time is long, and can only respite pain, numbness, but can not thoroughly effect a radical cure.Current doctor trained in Western medicine there is no effective medicine to this disease, often adopts anti symptom treatment, as taken the medicine of some antipyretic-antalgics during pain; Numbness person can select vitamin B group class medicine; Arthroncus has hydrops, and person can give therapy such as local extraction hydrops or partial closure etc.But facts have proved that these Therapeutic Method are all undesirable, just take stopgap measures and do not effect a permanent cure, the state of an illness easily recurs.
Summary of the invention
For the deficiencies in the prior art, the invention provides the Chinese medicine that a kind of instant effect, more rate are high, hyperosteogeny is treated in treatment that is that have no side effect.
Technical scheme of the present invention is such realization: a kind of Chinese medicine for the treatment of hyperosteogeny, and the medicine comprising following parts by weight is prepared from: Herba Ephedrae 6-12 part, Semen Cuscutae 8-11 part, Radix Angelicae Sinensis 6-12 part, Rhizoma Et Radix Notopterygii 4-8 part, Rhizoma Drynariae 10-15 part, Rhizoma Cyperi 8-12 part, Radix Aconiti 7-14 part, Radix Paeoniae Rubra 8-13.
Technical scheme of the present invention can be achieved in that
Treat a Chinese medicine for hyperosteogeny, the medicine comprising following parts by weight is prepared from: 8 parts, Herba Ephedrae, Semen Cuscutae 10 parts, Radix Angelicae Sinensis 9 parts, Rhizoma Et Radix Notopterygii 6 parts, Rhizoma Drynariae 12 parts, Rhizoma Cyperi 10 parts, Radix Aconiti 11 parts, Radix Paeoniae Rubra 9.
The preparation method of Chinese medicine of the present invention is: the Chinese medicine taking corresponding weight, will in medicinal mill for Chinese medicine pulverize, in the environment ventilated, contained humidity in medicated powder is removed in dry in the sun, crosses 150 mesh sieves; Load in Capsules according to quantity, be finished product.
The course for the treatment of: oral every day three times, early, middle evening services once, and warm water is sent down, and the intake of every day is 6 (6 grams), within one month, is a course for the treatment of, withdraws 5 days between each course for the treatment of.Within 30 days, be a course for the treatment of, the 3-5 course for the treatment of need be taken.
The pharmacology of each concrete ingredient is as follows:
Herba Ephedrae: pungent, micro-hardship, temperature.Lung meridian, urinary bladder channel.Diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema.
Semen Cuscutae: warm in nature, sweet in the mouth.Return liver,kidney,spleen warp.Nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, tomorrow, antidiarrheal.
Radix Angelicae Sinensis: sweet, pungent, warm.Return liver, the heart, spleen channel.Invigorate blood circulation; The all cards of main blood deficiency; The poly-ulcer sores of lump in the abdomen knot; Injury from falling down.：
Rhizoma Et Radix Notopterygii: acrid in the mouth, hardship, warm in nature.Enter bladder, kidney channel.Induce sweat cold expelling, expelling wind and dampness, pain relieving.
Rhizoma Drynariae: bitter, temperature.Enter liver, kidney two warp.The kidney invigorating, invigorates blood circulation, hemostasis.
Rhizoma Cyperi: acrid in the mouth, micro-hardship, micro-sweet, flat.Return liver, spleen, tri-jiao channel.Dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of QI to ease the stomach, menstruction regulating and pain relieving.
Radix Aconiti: acrid in the mouth, hardship, hot in nature.GUIXIN, liver,kidney,spleen warp.Expelling wind and removing dampness, antalgic.
Radix Paeoniae Rubra: bitter in the mouth, cold nature.Return Liver Channel.Clearing away heat and cooling blood, eliminating stasis to stop pain.
Function of the present invention and curing mainly: medicine of the present invention, according to theory of Chinese medical science, has: tendons relaxing and meridians dredging, tonification muscles and bones, strengthening the loins and invigorating the kidney, adjusts cloudy YANG invigorating, promoting blood circulation and detumescence, removing toxic substances analgesia.Cure mainly caused by prolapse of lumbar intervertebral disc and pressuring nerve thereof upper and lower extremities pain, numbness, tired to rise, the hyperosteogeny of the symptom such as unable, specifically good clinical effectiveness.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details:
Embodiment 1: a kind of Chinese medicine for the treatment of hyperosteogeny, the medicine comprising following parts by weight is prepared from: 6 parts, Herba Ephedrae, Semen Cuscutae 8 parts, Radix Angelicae Sinensis 6 parts, Rhizoma Et Radix Notopterygii 4 parts, Rhizoma Drynariae 10 parts, Rhizoma Cyperi 8 parts, Radix Aconiti 7 parts, Radix Paeoniae Rubra 8.
Embodiment 2: a kind of Chinese medicine for the treatment of hyperosteogeny, the medicine comprising following weight grams is prepared from: 12 parts, Herba Ephedrae, Semen Cuscutae 11 parts, Radix Angelicae Sinensis 12 parts, Rhizoma Et Radix Notopterygii 8 parts, Rhizoma Drynariae 15 parts, Rhizoma Cyperi 12 parts, Radix Aconiti 14 parts, Radix Paeoniae Rubra 13.
Embodiment 3: a kind of Chinese medicine for the treatment of hyperosteogeny, the medicine comprising following weight grams is prepared from: 8 parts, Herba Ephedrae, Semen Cuscutae 10 parts, Radix Angelicae Sinensis 9 parts, Rhizoma Et Radix Notopterygii 6 parts, Rhizoma Drynariae 12 parts, Rhizoma Cyperi 10 parts, Radix Aconiti 11 parts, Radix Paeoniae Rubra 9.
Chinese medicine in embodiment 1-3 takes the Chinese medicine of corresponding weight in the preparation, will in medicinal mill for Chinese medicine pulverize, in the environment ventilated, contained humidity in medicated powder is removed in dry in the sun, crosses 150 mesh sieves; Load in Capsules according to quantity, be finished product.
The present invention is not limited to above-mentioned preferred forms, anyone other any or akin products identical with the present invention drawn under enlightenment of the present invention, all drops within protection scope of the present invention.
The result of clinical observation of the present invention is as follows:
In the past few years, the present invention treats patient's totally 150 examples participating in statistics, and wherein: recovery from illness 122 example, effective 24 examples, invalid 4 examples, total effective rate reaches more than 96%.The present invention is directed to the treatment of acne, every day 3 times, each 2-4 grain, 1 month is a course for the treatment of, and general 2-3 the course for the treatment of cures.
Effective cure rate statistics of Chinese medicine of the present invention, criterion of therapeutical effect is as follows:
Cure: pain disappears, waist pressure pain disappears, and waist activity is accessible, does not affect work and daily routines;
Effective: pain relief, waist pressure pain alleviates, and the movable slight obstacle of waist, occurs that flank pain is uncomfortable when work or waist activity;
Invalid: symptom and sign and function are without improvement.
Model case:
Grandson, female, 58 years old; suffer from hyperosteogeny about 5 years, double knee joint pain, movable difficulty; walk, stand and upper equal pain downstairs; left side pain is heavy, feels nervous when night stretches one's legs, left knee stiffness, pain when sudden and violent; through Drug therapy of the present invention; after four months, symptom is clearly better, and walks, stands, and recovers normal activity.
Poplar, man, 71 years old; suffer from hyperosteogeny 3 years, double knee joint pain is more than 5 years, sits, pain in the lumbar region increases the weight of when bending over; the tired pain in companion both shoulders back is more than 2 years, and two upper limb is bitterly tired, unable; double knee joint pain, walks station and all aches, difficulty of squatting down; when standing, pain increases the weight of; through Drug therapy of the present invention, be almost recovered after six months, substantially recover normal activity.
Zhao so-and-so, man, 49 years old, cervical pain was more than 3 years, companioned with headache, tinnitus, feel sick, pain increases the weight of when two upper limb is tired heavy, both hands are numb, night sleeps, flank pain 3 years, increases the weight of half a year, walk, stand, pain increases the weight of when bending over, and takes Drug therapy of the present invention, fully recover after 4 months.
Claims (2)
1. treat a Chinese medicine for hyperosteogeny, it is characterized in that: the medicine comprising following parts by weight is prepared from: Herba Ephedrae 6-12 part, Semen Cuscutae 8-11 part, Radix Angelicae Sinensis 6-12 part, Rhizoma Et Radix Notopterygii 4-8 part, Rhizoma Drynariae 10-15 part, Rhizoma Cyperi 8-12 part, Radix Aconiti 7-14 part, Radix Paeoniae Rubra 8-13.
2. a kind of Chinese medicine for the treatment of hyperosteogeny according to claim 1, is characterized in that: the medicine comprising following parts by weight is prepared from: 8 parts, Herba Ephedrae, Semen Cuscutae 10 parts, Radix Angelicae Sinensis 9 parts, Rhizoma Et Radix Notopterygii 6 parts, Rhizoma Drynariae 12 parts, Rhizoma Cyperi 10 parts, Radix Aconiti 11 parts, Radix Paeoniae Rubra 9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510174693.0A CN104721456A (en) | 2015-04-14 | 2015-04-14 | Chinese herbal medicine for treating osteoproliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510174693.0A CN104721456A (en) | 2015-04-14 | 2015-04-14 | Chinese herbal medicine for treating osteoproliferation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104721456A true CN104721456A (en) | 2015-06-24 |
Family
ID=53446252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510174693.0A Pending CN104721456A (en) | 2015-04-14 | 2015-04-14 | Chinese herbal medicine for treating osteoproliferation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104721456A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010140170A1 (en) * | 2009-06-05 | 2010-12-09 | Sunev Pharma Solution Limited | Topical micro-emulsions for the treatment of rheumatic disorders |
| CN102824500A (en) * | 2012-09-19 | 2012-12-19 | 窦小伟 | Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc and osteoproliferation |
| CN104127625A (en) * | 2014-08-01 | 2014-11-05 | 张媛媛 | Traditional Chinese medicine for treating hyperosteogeny |
-
2015
- 2015-04-14 CN CN201510174693.0A patent/CN104721456A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010140170A1 (en) * | 2009-06-05 | 2010-12-09 | Sunev Pharma Solution Limited | Topical micro-emulsions for the treatment of rheumatic disorders |
| CN102824500A (en) * | 2012-09-19 | 2012-12-19 | 窦小伟 | Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc and osteoproliferation |
| CN104127625A (en) * | 2014-08-01 | 2014-11-05 | 张媛媛 | Traditional Chinese medicine for treating hyperosteogeny |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102793883B (en) | Plaster for treating intervertebral disc protrusion and cervical spondylosis | |
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN105770734A (en) | Traditional Chinese medicine composition for treating joint sore symptoms of osteoarthritis through external use | |
| CN102824500A (en) | Traditional Chinese medicine for treating protrusion of lumbar intervertebral disc and osteoproliferation | |
| CN101450197A (en) | Traditional Chinese medicine for treating rheumatism, rheumatoid disease | |
| CN104984191A (en) | Traditional Chinese medicine composition for treating acute lumbar muscle sprain | |
| CN102716261B (en) | Wind-damp expelling traditional Chinese medicine powder | |
| CN107375845A (en) | External composition for dispelling wind, eliminating dampness, clearing and activating channels and collaterals and use method thereof | |
| CN101664455A (en) | Chinese medicinal composition for treating lumbago and preparation method | |
| CN105816842A (en) | Medicinal liquor capable of killing bacteria, dispelling wind, removing obstruction in meridians and relieving pain and preparation method thereof | |
| CN104288596B (en) | A kind of Chinese medicine composition for treating ankylosing spondylitis | |
| CN106362066A (en) | Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof | |
| CN102552461B (en) | Medicinal moxa roll for treating knee osteoarthritis | |
| CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
| CN101780257B (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
| CN105687570A (en) | Traditional Chinese medicinal composition for treating sciatica | |
| CN102018858B (en) | Traditional Chinese medicine composition for treating sprain | |
| CN104721456A (en) | Chinese herbal medicine for treating osteoproliferation | |
| CN103877467A (en) | Traditional Chinese medicinal capsule for treating hyperosteogeny | |
| CN102416053A (en) | Medicinal moxaroll for treating sciatica and preparation method thereof | |
| CN103083489B (en) | Traditional Chinese medicine wine for treating lumbar spondylosis, cervical spondylosis, early osteoproliferation and old wounds | |
| CN103721183B (en) | A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia | |
| CN103550620B (en) | A kind of externally-applied medicinal composition treating rheumatalgia | |
| CN106109965A (en) | A kind of Chinese medicine composition treating flaccidity disease | |
| CN104758798A (en) | Traditional Chinese medicine composition for treating osteoarthrosis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150624 |